RE:RE:RE:Biotech Take Over - Wall Street JournalAlthough Abiomed is a medical device company its current market cap is US$17 Billion.
A market cap of US$17 Billion is significant for a medical device company in the auxilliary heart pump device business when the global heart pump device market size is estimated to be USD$ 5.5 billion by 2026. Up from US$1.6 Billion in 2020.
https://www.marketsandmarkets.com/Market-Reports/heart-pump-device-market-237125725.html
https://www.globenewswire.com/en/news-release/2022/09/08/2512126/0/en/Heart-Pump-Device-Market-Size-and-Upcoming-Technological-Innovations-Will-Boom-in-2022-2028-Analyzed-by-Size-Share-Trends-Key-Players-Future-Growth-Outlook.html
In contrast the global immune checkpoint inhibitors market size was exhibited at US$ 31.4 billion in 2021 and it is expected to hit around US$ 148.1 billion by 2030 with a registered CAGR of 18.81% during the forecast period 2022 to 2030.
https://www.precedenceresearch.com/immune-checkpoint-inhibitors-market
Meanwhile the global oncology markt was valued at US$ 286.04 Billion in 2021 and is expected to reach over US$ 581.25 Billion by 2030.
The breast cancer market size in 2021 was US$57.7 Billion.